PAA 2.50% 20.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1293

  1. 2,943 Posts.
    lightbulb Created with Sketch. 1084
    I would respond we have a very small minded board with no understanding of the MND and neurodegenerative disease market.

    Small minds = mental midgets
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.